Putting a difficult year in the rearview or shedding an older image were common talking points among biopharma CEOs on day one of the JPM 2024 conference.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,